| Dr Daryl Rampersad, MD | |
|
3400 Old Milton Pkwy Ste A130, Alpharetta, GA 30005-4417 | |
| (770) 664-8898 | |
| (770) 772-4377 |
| Full Name | Dr Daryl Rampersad |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 3400 Old Milton Pkwy Ste A130, Alpharetta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871938969 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 281021 (New York) | Secondary |
| 207Q00000X | Family Medicine | 074327 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northside Urgent Care Holding Llc | 4587984695 | 61 |
News Archive
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.
Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.
The Asian Cancer Research Group (ACRG)—an independent, not-for-profit company established by Eli Lilly and Company, Merck (known as MSD outside the United States and Canada) and Pfizer Inc.—in collaboration with BGI—the world's largest genomics organization—today announced the publication of results from a whole genome-wide study of recurrent hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) in Nature Genetics.
› Verified 4 days ago
| Entity Name | Northside Urgent Care Holding Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679962237 PECOS PAC ID: 4587984695 Enrollment ID: O20150513000795 |
News Archive
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.
Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.
The Asian Cancer Research Group (ACRG)—an independent, not-for-profit company established by Eli Lilly and Company, Merck (known as MSD outside the United States and Canada) and Pfizer Inc.—in collaboration with BGI—the world's largest genomics organization—today announced the publication of results from a whole genome-wide study of recurrent hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) in Nature Genetics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daryl Rampersad, MD 615 Beaver Ruin Rd Nw, Suite B, Lilburn, GA 30047-3401 Ph: (770) 935-8616 | Dr Daryl Rampersad, MD 3400 Old Milton Pkwy Ste A130, Alpharetta, GA 30005-4417 Ph: (770) 664-8898 |
News Archive
Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.
It is estimated that 174,470 new cases of lung cancer will be diagnosed in the United States in 2006. Lung cancer is the major cause of cancer-related mortality in both men and women, with an estimated 162,460 deaths expected to occur in 2006.
Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA.
The Asian Cancer Research Group (ACRG)—an independent, not-for-profit company established by Eli Lilly and Company, Merck (known as MSD outside the United States and Canada) and Pfizer Inc.—in collaboration with BGI—the world's largest genomics organization—today announced the publication of results from a whole genome-wide study of recurrent hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) in Nature Genetics.
› Verified 4 days ago
Elizabeth T Sergile, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Old Milton Pkwy, Ste A130, Alpharetta, GA 30005 Phone: 770-664-8898 Fax: 770-772-4377 | |
Dr. Stuart Irwin Levin, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1040 Cambridge Sq, Suite E, Alpharetta, GA 30009 Phone: 770-569-2020 Fax: 770-569-5550 | |
Dr. Thomas E Reeths, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 5655 Atlanta Hwy Ste A, Alpharetta, GA 30004 Phone: 770-343-6364 | |
Dr. Satishkumar Mudduranganath Ganjam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3905 Brookside Pkwy Ste 300, Alpharetta, GA 30022 Phone: 770-442-1911 Fax: 707-442-0306 | |
Mr. Pedro Antonio Ramirez, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 261 North Main Street, Alpharetta, GA 30004 Phone: 770-664-5660 Fax: 770-663-8672 | |
Dr. Mark James Sakr, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3400 Old Milton Pkwy Ste C190, Alpharetta, GA 30005 Phone: 855-647-7678 | |
Dr. Jignesh R Dholaria, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 260 Rucker Rd Ste 400, Alpharetta, GA 30004 Phone: 470-956-4540 Fax: 770-667-9783 |